KP.3.1.1 “has an additional mutation in its spike protein,” Dr. Adalja says. (The spike protein is what SARS-CoV-2 uses to ...

SARS-CoV-2, the virus responsible for COVID-19, infects cells by binding its spike protein to angiotensin-converting enzyme 2 (ACE2) receptors. Blocking this interaction with inhibitors could prevent ...

However, mutations in the spike protein can alter its structure, reducing the effectiveness of these inhibitors. In a significant breakthrough, a research team led by Professor Yoshinori Fujiyoshi and ...

The two strains feature several mutations each, including genetic changes that impact the key component of the virus that vaccines target: The spike protein. The two mutations are more contagious ...

In the early, uncertain days of the coronavirus pandemic, scientists delivered one comforting pronouncement: The virus that caused COVID mutates rather slowly. If that remained true, the virus would ...

However, mutations in the spike protein can alter its structure, reducing the effectiveness of these inhibitors. In a significant breakthrough, a research team led by Professor Yoshinori Fujiyoshi ...

The B.1.1.7 strain of SARS-CoV-2 is a collection of genetic changes, not just a single mutation. Some of them occurred at the spike protein level, which explains why scientists are retesting the ...

They produce “neutralizing antibodies” that might recognize parts of the spike protein and bind to it ... Because the genome is so large, many mutations could occur during replication that ...

A vaccine's ability to generate long-lasting, high-affinity antibodies hinges on a delicate balance. Upon exposure to a vaccine or pathogen, B cells scramble to refine their defenses, rapidly mutating ...

However, mutations in the spike protein can alter its structure, reducing the effectiveness of these inhibitors. In a significant breakthrough, a research team led by Professor Yoshinori Fujiyoshi ...